The cyclo-oxygenase (COX) and lipoxygenase (LOX) pathways belong to the eicosanoid synthesis pathway, a major component of the chronic inflammatory process occurring in Alzheimer's disease (AD). Clinical studies reported beneficial effects of COX inhibitors, but little is known about the involvement of LOXs in AD pathogenesis. b-amyloid peptide (Ab) accumulation contributes to neurodegeneration in AD, but mechanisms underlying Ab toxicity have not been fully elucidated yet. Here, using an antisense oligonucleotide-based strategy, we show that blockade of 12-LOX expression prevents both Ab-induced apoptosis and overexpression of c-Jun, a factor required for the apoptotic process, in cortical neurons. Conversely, the 12-LOX metabolite, 12(S)-HETE (12(S)-hydroxy-(5Z, 8Z, 10E, 14Z)-eicosatetraenoic acid), promoted c-Jun-dependent apoptosis. Specificity of the 12-LOX involvement was further supported by the observed lack of contribution of 5-LOX in this process. These data indicate that blockade of 12-LOX expression disrupts a c-Jun-dependent apoptosis pathway, and suggest that 12-LOX may represent a new target for the treatment of AD.
Introduction
Alzheimer's disease (AD) involves a chronic CNS inflammatory process that contributes to the neuronal loss and all the pathological features of the disease. 1 A major component of this process is the eicosanoid synthesis pathway, which involves two major routes: the cyclo-oxygenase (COX) and the lipoxygenase (LOX) pathways. 2 Clinical studies showing that chronic treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with a delay of AD onset focused attention on the beneficial effect of COX inhibitors. 3 In contrast, very few studies evaluated the potential interest of LOX inhibitors in the treatment of AD.
One of the main features of AD is the presence of senile plaques in the brain that contain deposits of the 40-42 aminoacid b-amyloid peptide (Ab). The central role of Ab in AD pathogenesis has been well documented. 4, 5 In particular, the rate of accumulation of this peptide correlated with the extent of neurodegeneration. 6 Furthermore, injection of Ab aggregates in the rat brain caused neuronal death and behavioral alterations. 7, 8 Ab generated apoptosis in several in vitro models, associated with caspase activation, [9] [10] [11] [12] [13] [14] both of which were also documented in AD brains. 15, 16 Recent data further evidenced a major role of the transcription factor c-Jun in mediating Ab-induced apoptosis. [17] [18] [19] Overexpression of this factor was detected in neurons surrounding senile plaques. 20 However, the exact signaling pathways underlying Ab-induced apoptosis have not been fully elucidated yet.
LOXs incorporate oxygen into specific sites of polyunsaturated fatty acids and are generally classified as 5-, 12-or 15-LOXs depending on the site of incorporation. 21 Both 12-and 5-LOX are expressed in the brain and especially in neurons. 22, 23 LOXs represent important regulators of cell proliferation and death in different cell types. [24] [25] [26] Moreover, a few studies suggested the involvement of 5-or 12-LOX in pathways leading to neuronal death, such as kainic acid excitotoxicity, 27 apoptosis induced by prion peptide 28 and oxidative glutamate toxicity. 23 In this work, we show that blockade of 12-LOX expression protects cortical neurons from Ab-induced apoptosis, through disruption of a c-Jun-dependent apoptosis pathway. These findings suggest that 12-LOX might be considered as a new target for the treatment of AD.
Results
Blockade of 12-LOX expression suppresses Ab-induced apoptosis and reduces Ab-induced caspase activation 12 -LOX was previously shown to mediate both oxidative glutamate toxicity and apoptosis induced by buthionine sulfoximine (BSO) in primary cultures of rat cortical neurons, two processes involving glutathione depletion. 23 Alteration of glutathione metabolism is one of the events triggered by Ab 29 and was reported to occur in AD, 30 which suggested that this LOX might also participate in Ab-induced apoptosis. Indeed, previous studies using broad-spectrum LOX inhibitors such as nordihydroguaiaretic acid on hippocampal cultures led to equivocal results, reporting either a lack of protection against Ab-induced apoptosis 31 or a protective action at high concentrations. 32 Using more selective inhibitors, we recently suggested a participation of 12-LOX in apoptosis triggered by Ab in cortical neurons. 33 However, inhibitors can only provide circumstantial evidence about the role of LOXs in Ab-induced toxicity, since most of these compounds also possess other characteristics such as proor antioxidant properties, 25, 26, [34] [35] [36] which might lead to LOX-independent effects. In order to assess the protective potential of 12-LOX blockade towards Ab-induced apoptosis, we used here an antisense oligonucleotide-based strategy.
When extracts of cortical cells were probed with an antibody raised against murine leukocyte 12-LOX, two bands (75-78 kDa) were detected in Western blot experiments ( Figure 1a) . A similar doublet pattern was already observed in previous studies on these cultures. 23 As shown in Figure 1a , pretreatment of cortical cells for 48 h with the antisense 12-LOX oligonucleotide induced an important decrease in the expression of 12-LOX protein. When normalized to corresponding actin levels, the effect of the oligonucleotide represented an 85% decrease in 12-LOX protein levels.
As illustrated in Figure 1b , a 24-h treatment of cortical cells with 25 mM Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] increased the percentage of apoptotic cells, as assessed by 4 0 ,6-diamidino-2-phenylindole (DAPI) staining. This proapoptotic effect of Ab was totally suppressed by a 48-h pretreatment of the cells with the 12-LOX antisense oligonucleotide, whereas the sense or the scramble 12-LOX oligonucleotide did not show any protective action (Figure 1b) . Similar results were obtained when apoptosis was assessed by TUNEL experiments (Figure 1c) .
Numerous studies indicated that Ab-induced cell death was associated with the activation of the caspase cascade. [10] [11] [12] [13] [14] We therefore investigated the effect of 12-LOX downregulation on Ab-induced caspase activation. As shown in Figure 2 , treatment of cortical cells with 25 mM Ab led to the activation of caspase-2, -3 and -8. Pretreatment with the 12-LOX antisense oligonucleotide strongly inhibited Ab-induced activation of all three caspases (Figures 2a-c) . The oligonucleotide effect represented 6774, 6874 and 7872% (n ¼ 3 independent experiments) decreases in the Ab-induced activation of caspase-2, -3 and -8, respectively. No alteration of the Ab-induced caspase activation was observed upon treatment with the 12-LOX sense oligonucleotide (Figures 2d-f) .
The protection against Ab-induced apoptosis afforded by 12-LOX blockade further suggested a proapoptotic involvement of 12-LOX in cortical neurons. Previous studies 23, 37 indicated that the 12-LOX isoform present in primary cultures of rat cortical neurons was the 12-LOX cloned from rat brain, 38 belonging to the family of leukocyte-type 12-LOXs. Like other members of this family, rat brain 12-LOX presented high similarity with 15-LOX. However, a striking characteristic of this isoform was that it generated predominantly 12(S)-hydroxy-(5Z, 8Z, 10E, 14Z)-eicosatetraenoic acid (12(S)-HETE), with only small amounts of 15(S)-HETE. 38, 39 We therefore evaluated whether exogenous 12(S)-HETE could induce apoptosis in cortical cells. As illustrated in Figure 3 , a concentration-dependent increase in the percentage of apoptotic cells was observed following a 24-h treatment of the cultures with 12(S)-HETE. Previous studies indicated that 5-LOX could play a critical role in neuronal cell death, mediating, for instance, kainic acidinduced excitotoxicity 27 and apoptosis generated by prion peptide. 28 We recently reported that the 5-LOX inhibitor, caffeic acid, did not counteract apoptosis induced by Ab in cortical neurons, suggesting that 5-LOX was not involved in this degeneration process. 33 In the present study, we further evaluated this hypothesis through the same strategy as that used for 12-LOX. As shown in Figure 4a , pretreatment of cortical cells for 48 h with the antisense 5-LOX oligonucleotide induced an important decrease in the expression of the 5-LOX protein.
When normalized to corresponding actin levels, the effect of the oligonucleotide represented a 75% decrease in 5-LOX protein levels.
However, at variance with what was observed above for 12-LOX, such a pretreatment with the 5-LOX antisense oligonucleotide did not counteract the proapoptotic effect of Ab (Figure 4b) . Similarly, no effect was observed with the corresponding sense oligonucleotide (Figure 4b 
Blockade of 12-LOX expression disrupts a c-Jun-dependent Ab-induced apoptotic pathway
Several studies revealed that the transcription factor c-Jun represented a common mediator in neuronal apoptosis triggered by several stimuli, such as growth factor deprivation, oxidative stress or excitotoxicity. [40] [41] [42] Moreover, both c-Jun expression and activation were found to be increased following exposure of neurons to Ab, and recent data suggested a 12-Lipoxygenase and amyloid peptide toxicity A Lebeau et al critical role of this transcription factor in Ab-induced apoptosis. [17] [18] [19] 43, 44 We therefore investigated whether 12-LOX blockade could interfere with such an Ab-induced c-Jundependent apoptotic pathway in cortical cells.
We first examined the effect of 12-LOX antisense oligonucleotide on Ab-induced increase in c-Jun expression. In agreement with our previous observations, 33 activation. 18 However, nothing had been reported yet on the consequences of c-Jun downregulation on Ab-induced caspase activation. We therefore investigated the effect of c-Jun antisense oligonucleotide on caspase activities triggered by Ab in our experimental model. As illustrated in Figure 7c , pretreatment of cortical cultures with c-Jun antisense oligonucleotide decreased the Ab-induced activation of caspase 8. In contrast, no alteration of the Ab-induced activation of caspase-2 and -3 was observed (Figures 7a and  b) . Treatment with the c-Jun sense oligonucleotide did not alter Ab-induced activation of caspase-2, -3 and -8 ( Figures  7d-f) . These data indicated an involvement of c-Jun in the activation of caspase-8 triggered by Ab.
Taken together, our findings indicated both an involvement of 12-LOX in the Ab-mediated induction of c-Jun and a participation of this transcription factor in the apoptotic process, suggesting that 12-LOX lay upstream of c-Jun in the Ab-induced apoptotic pathway. The ability of 12-LOX to trigger a c-Jun-dependent apoptotic pathway was further investigated by evaluating the role of c-Jun in apoptosis induced by 12(S)-HETE.
As presented in Figure 8a , a 24-h treatment of cortical cells with 12(S)-HETE induced a concentration-dependent increase in the percentage of c-Jun-positive neurons, which strikingly paralleled the proapoptotic action of this compound ( Figure 3) . Furthermore, pretreatment with the c-Jun antisense oligonucleotide totally protected cortical cells from apoptosis induced by 12(S)-HETE, whereas no protection was observed following treatment with the corresponding sense oligonucleotide (Figure 8b ). These data indicated that the 12-LOX metabolite, 12(S)-HETE, induced a c-Jundependent apoptotic pathway in cortical neurons.
Discussion
In the present report, we demonstrated that downregulation of 12-LOX suppressed apoptosis, strongly decreased the activation of caspase-2, -3 and -8 and prevented c-Jun overexpression induced by Ab in rat cortical neurons. The requirement of c-Jun for the death process induced by Ab in these cells was further indicated by the prevention of both Abinduced apoptosis and caspase-8 activation following pretreatment with a c-Jun antisense oligonucleotide. Moreover, we showed that the 12-LOX metabolite 12(S)-HETE induced apoptosis, associated with an increase in c-Jun expression and suppressed by a c-Jun antisense oligonucleotide. These data suggest that blockade of 12-LOX expression protects cortical neurons from Ab-induced apoptosis, through disruption of a c-Jun-dependent apoptosis pathway. The specificity of involvement of 12-LOX in this process was further supported by both the lack of protection observed following downregulation of 5-LOX expression and the lack of toxicity of the 5-LOX metabolite, 5(S)-HETE, in this experimental model.
It has been reported that LOXs play an important role in neuronal metabolism and function. 45 Indeed, LOX metabolites were found to be synthesized in both neurons and glial cells. 21, [46] [47] [48] Some of them, such as 5-and 12-hydroxyeicosatetraenoic acids, have been reported to exert various actions on neurons, including modulation of Na-K ATPase activity, 49 neurotransmitter release 50 or alteration of membrane potential. 51, 52 LOXs also act as regulators of cell proliferation and death, and have been implied in the mediation of apoptosis induced by various physical or chemical agents such as UV light, oxidative stress or receptor ligands 25, 26 In contrast, only a small number of studies investigated the involvement of LOXs in the various signaling pathways leading to neurodegeneration. However, data obtained thus far suggest a crucial participation of these enzymes in several of these pathways. For instance, 5-LOX was shown to mediate kainic acid-induced excitotoxicity 27 and apoptosis generated by prion peptide. 28 With regard to 12-LOX, this enzyme was previously shown to mediate both oxidative glutamate toxicity and BSO-induced apoptosis. 23 In a recent study, 33 we showed that baicalein, a 12-LOX inhibitor, protected cortical neurons from Ab-induced apoptosis, suggesting a role for 12-LOX in the apoptotic process triggered by Ab in these cells.
The present results indicate that downregulation of 12-LOX expression by an antisense oligonucleotide leads to the suppression of Ab-induced apoptosis. When combining these data to those previously obtained with the 12-LOX inhibitor, it thus appears that protection against neuronal death induced by Ab could be achieved upon blockade of 12-LOX through either inhibition of the enzyme or downregulation of its expression. Moreover, it is now well documented that caspases participate in Ab-induced apoptosis, [10] [11] [12] [13] and that their activation correlates with apoptotic features in AD brains. 53, 54 In particular, caspase-2, -3 and -8 have been reported to be activated in neurons following Ab treatment. [10] [11] [12] 14, 18 We show here that the protective action of 12-LOX antisense oligonucleotide against Ab-mediated apoptosis is associated with decreases in the activation of these caspases. Taken together, these data indicate that 12-LOX blockade counteracts the apoptotic process triggered by Ab in cortical cells.
Both pro-and antiapoptotic roles of LOXs have been reported in various cell types. 25, 26 However, the protection afforded by 12-LOX blockade against Ab-induced apoptosis as well as the induction of apoptosis by 12(S)-HETE observed in the present work favored a proapoptotic involvement of this enzyme in cortical cells. These findings add to previous studies showing that 12-LOX mediated apoptosis induced by other stimuli, such as glutamate or BSO, 23 and suggest that this LOX might represent a common intermediate in neurodegenerative processes triggered by various insults.
In the present study, we also demonstrated both a lack of protection of cortical neurons by pretreatment with a 5-LOX antisense oligonucleotide and a lack of toxicity of the 5-LOX metabolite, 5(S)-HETE. These findings add to our previous observations showing that the 5-LOX inhibitor, caffeic acid, did not counteract Ab-induced apoptosis in this experimental system. 33 Taken together, these data suggest that 5-LOX does not participate in the apoptotic process induced by Ab in cortical neurons, representing an important support to the specificity of the role of 12-LOX pathway in this process.
It should be stressed, however, that these results do not rule out the possibility of a participation of 5-LOX in the pathology of AD, since this pathology most probably encompasses several other parameters, which are not present in this in vitro model. In this respect, it is interesting to note that a relationship between 5-LOX promoter polymorphism and AD onset was recently reported. 55 One of the typical feature found in post-mortem studies on brains from AD patients is an overexpression of c-Jun, 56 which is also a hallmark of Ab-induced apoptosis in neuronal cultures. 17, 44 This transcription factor was found to play a major role in Ab-induced neurotoxicity. 17, 18 In the present study, we showed that the protective action of 12-LOX antisense oligonucleotide against Ab-mediated toxicity was associated with the suppression of c-Jun overexpression. Furthermore, pretreatment with a c-Jun antisense oligonucleotide protected cortical neurons from Ab-induced apoptosis and decreased the activation of caspase-8, indicating that this transcription factor was involved in the death process induced by Ab under our experimental conditions. The data obtained with the c-Jun antisense oligonucleotide corroborate previous studies performed on cortical cultures, showing that dominant-negative mutants of c-Jun afforded protection against Ab-induced apoptosis. 18 These findings suggested that 12-LOX was positioned upstream of c-Jun in the apoptotic pathway induced by Ab. They also suggested that this enzyme could represent a critical step in the triggering of a c-Jun-dependent apoptosis pathway. This hypothesis was further supported by our observation that the 12-LOX metabolite, 12(S)-HETE, induced a c-Jun-dependent death process. Interestingly, although such an involvement of 12-LOX in the induction of c-Jun-dependent apoptosis had not been previously evidenced, it lies in accordance with some data from literature since BSOinduced apoptosis, shown to be mediated by 12-LOX, 23 was also reported to be c-Jun dependent. 57 The relationship between c-Jun and Ab-induced activation of caspases has not been fully elucidated yet. The activation of caspase-8 upon Ab treatment of cortical neurons was recently suggested to occur through a c-Jun-mediated induction of Fas ligand. 18 Our observation that Ab-induced caspase-8 activation is prevented by a c-Jun antisense oligonucleotide provides evidence for an involvement of this factor in the activation of caspase-8. Interestingly, the lack of effect of the c-Jun antisense oligonucleotide on caspase-2 and -3 activations lies, in contrast, with the previously reported inhibition of these caspases upon treatment with CEP-1347, an inhibitor of the c-Jun N-terminal kinase (JNK). 19, 58 It could thus be postulated that the effect of CEP-1347 on these two caspases reflected disruption of the JNK action on a target different from c-Jun, such as activating transcription factor 2 or Elk1. 59 It should also be noticed that, despite its lack of effect on the activation of caspase-2 and -3, the c-Jun antisense oligonucleotide afforded protection of cortical neurons against Ab-induced apoptosis. Whereas the involvement of caspase-3 in Ab-induced neuronal apoptosis still remains controversial, 10,13,60 caspase-8 activation 11 and caspase-2 activation 12, 61 were separately identified as necessary steps for Ab-induced neuronal death. Our results support the hypothesis that the induction of these two caspases is needed for completion of the apoptotic process.
The involvement of c-Jun in the Ab-induced activation of caspase-8 further suggests the existence of a causal link between the suppression of c-Jun induction and the decrease in caspase-8 activation observed following 12-LOX downregulation. However, the decreased activation of caspase-2 and -3, also obtained under those experimental conditions, cannot be explained by the sole disruption of c-Jun induction and would thus imply additional mechanisms. For instance, as mentioned above for the action of CEP-1347, the effect of 12-LOX downregulation on these two caspases could involve decreased activation of other targets of the JNK signaling pathway.
The beneficial effects of NSAIDs in AD focused attention on the therapeutic interest of COX inhibitors. 3 However, the present study suggests that the 12-LOX pathway could also play an important role in this pathology. Indeed, the 12-LOX inhibitor baicalein is the main component of an herbal medicine (Sho-Saiko-To) commonly administered in Asian countries to outpatients with chronic hepatitis. 62 Our findings suggest that such compounds may also offer new potential strategies in the pharmacological treatment of AD.
Materials and Methods

Primary neuronal culture
Rat cortical cultures were prepared from 17-day-old embryonic Wistar rats as described previously. 33, 63 The culture medium consisted of minimum 
Western blot analysis
Cells from six wells were washed with phosphate-buffered saline (PBS), and total proteins were extracted by scraping the cells in 100 ml of protein extracting buffer (10 mM Tris HCl, pH 7.5, 150 mM NaCl, 0.5% NP-40) containing 0.5 mM EDTA, 1 mM EGTA and phosphatase and protease inhibitors (0.5 mM sodium orthovanadate, 1 mM okadaic acid, 1 mg/ml Ntosyl-L-phenylalanine chloromethyl ketone, 1 mg/ml Na-p-tosyl-L-lysine chloromethyl ketone, 20 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin, 10 mg/ml aprotinin and 5 mg/ml pepstatin). Lysates were then sonicated and centrifuged, the resulting supernatants were collected and protein concentrations were determined by BCA assay (Pierce, CA, USA). Samples were mixed with 2 Â Laemmli sample buffer and heated at 901C for 5 min. 
Quantification of apoptosis
To detect morphological evidence of apoptosis, cell nuclei were visualized following DNA staining with the fluorescent dye DAPI (Sigma, St. Louis, MO, USA). Cells were rinsed with PBS, fixed for 20 min in formalin (Sigma, St. Louis, MO, USA), rinsed with PBS and then incubated for 10 min with DAPI (1 mg/ml PBS). After washing with PBS, cultures were examined using fluorescence microscopy (Microphot FX, Nikon France, Champignysur-Marne, France), and the percentage of apoptotic nuclei with condensed or fragmented chromatin was evaluated.
Detection of apoptosis was also evaluated through TUNEL labeling using the in situ Death Detection Kit POD (Roche Applied Science, Mannheim, Germany). Following DAPI staining, cells were subjected to TUNEL labeling according to the instructions of the manufacturer. 
c-Jun immunocytochemistry
Caspase assay
Caspase activities were assayed using AMC (7-amino-4-methylcoumarin)-related fluorogenic substrates (Alexis Biochemicals, San Diego, CA, USA): Ac-VDVAD-AMC for caspase-2, Ac-DEVD-AMC for caspase-3 and Ac-IEPD-AMC for caspase-8. Cortical neurons were harvested following a 24-h treatment with 25 mM Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . To measure caspase activity, cells were washed once with ice-cold PBS, and 250 ml ice-cold extraction buffer was added directly to the cultures. The extraction buffer consisted of 50 mM HEPES, 0.1 mM EDTA, 1 mM dithiothreitol, 0.1% CHAPS, 0.1% Triton X-100, 0.5 mM PMSF and 1 mg/ml pepstatin and aprotinin. After 15 min incubation on ice, the extraction buffer was removed, sonicated, centrifuged for 5 min at 17 000 Â g at 41C and 100 ml of supernatant was added to each well of a 96-well plate. Then, 100 ml of 20 mM fluorogenic substrate were added to each well to give a final substrate concentration of 10 mM. Plates were incubated at 371C and cleavage of the fluorogenic substrate was measured over 2 h with a Spectrafluor fluorometer (TECAN France, Trappes, France) (excitation wavelength: 365 nm; emission wavelength: 460 nm). Protein concentration was determined by the Biorad Protein Assay (Bio-Rad Laboratories, München, Germany).
Statistical analysis
All experiments were performed at least three times. All values are presented as means7S.E.M. Statistical analysis of data was carried out using ANOVA variance analysis followed by Dunnett's or Newman-Keuls tests, using Instat software (GraphPad, San Diego, CA, USA). Differences at Po0.05 were considered as significant.
